返回
化工社化工社化学信息打印报告 · 仅供科研参考
HRID 770生成日期:2026年10月23日

N-benzyloxycarbonyl-beta-benzyl-L-aspartyl-D-isoleucine (S)-alpha-ethylbenzylamide → alpha-L-aspartyl-D-isoleucine (S)-alpha-ethylbenzylamide

https://huagongshe.com/zh-CN/reaction/770

反应方程式

参与物

角色名称HCID投料
反应物N-benzyloxycarbonyl-beta-benzyl-L-aspartyl-D-isoleucine (S)-alpha-ethylbenzylamideHCID 53679369—
催化剂HCID 178418390HCID 178418390—
溶剂(5BETA,17BETA)-17-羟基-17-(甲基-D3)-2'H-雄甾-2-烯并[3,2-C]吡唑-5'(1'H)-酮HCID 887—
溶剂聚[6-[4-(4-氰基苯基)苯氧基]己基甲基丙烯酸酯]HCID 962—
产物alpha-L-aspartyl-D-isoleucine (S)-alpha-ethylbenzylamideHCID 5426267272.3%

反应步骤

To a suspension of 2.81 g (4.7 mmols) of N-benzyloxycarbonyl-β-benzyl-L-aspartyl-D-isoleucine (S)-α-ethylbenzylamide in 150 ml of methanol and 50 ml of water was added 2.0 g of 10% Pd-carbon (water content 50%). The mixture was reduced under hydrogen at room temperature for 5 hours. The catalyst was removed by filtration, and the resulting filtrate was concentrated under reduced pressure to be 20 ml. The crystals thus precipitated were taken out by filtration and dried to obtain 1.22 g (3.4 mmols) of α-L-aspartyl-D-isoleucine (S)-α-ethylbenzylamide.

来源与证据

DOI10.6084/m9.figshare.5104873.v1
专利号US05723165
来源数据集uspto-grants-1998_03
ORD IDord-b4a1a9f06c874053b3ad0f85aaa15884
来源说明uspto-grants-1998_03